Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

PHASE3TerminatedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

April 30, 2009

Study Completion Date

July 31, 2009

Conditions
Prostate Cancer
Interventions
DRUG

leuprolide acetate

17 mg i.m.

Trial Locations (8)

12601

Hudson Valley Urology, Poughkeepsie

19010

Center for Urologic Care, Bryn Mawr

27103

Piedmont Medical Research, Winston-Salem

29572

Carolina Urologic Research Center, Myrtle Beach

34655

Advanced Research Institute, New Port Richey

37209

Urology Associates, Nashville

78229

Urology San Antonio Research, PA, San Antonio

08648

Lawrenceville Urology, Lawrenceville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GP-Pharm

INDUSTRY